Hologic (HOLX) Tops Q3 EPS by 4c, provides guidance

Hologic (NASDAQ: HOLX) reported Q3 EPS of $1.06, $0.04 better than the analyst estimate of $1.02. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1 billion.

GUIDANCE:

Hologic sees FY2024 EPS of $4.04-$4.11, versus the consensus of $4.07. Hologic sees FY2024 revenue of $4.02-4.07 billion, versus the consensus of $4.031 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Veeva Systems (VEEV) Tops Q2 EPS by 13c; Offers Guidance
• CrowdStrike shares jump on earnings beat, raised outlook